The results are for the full year so we should see more detail.
It’s a simple waiting game regarding MED so I’m not expecting any news there. But I’m hoping for a good update on TPR. I still think the new trademark “Dermamax” applied for by Thornton & Ross relates to TPR and the application has recently been published ……….
……… so we’re about a couple of months off registration. And I still think the application was due to positive responses from the MHRA which may be touched upon in the results. If so, this could have a significant positive impact in that it shows Thornton & Ross’s commitment (unlike previous partnerships) and could pave the way for a decent milestone payment on approval and also the possibility of further regional deals for TPR with Thornton & Ross a likely candidate given their commitment to the UK deal. In turn this could solve any part 2 Phase 3 MED funding issues but I think positive part 1 results will see MED (or FUM as a whole) being sold anyway.